Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus valsartan after a missed dose during exercise in mild to moderate hypertension
2008-005500-10Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in essential hypertension and hypertension (HTN) comparing Aliskiren monotherapy with Valsartan monotherapy (2 arms). Primary endpoints: Primary objective endpoint 1 and Primary objective endpoint 2. Started Oct 2008; status: completed.
02
Drugs
aliskirenvalsartan
03
Conditions
essential hypertensionhypertension (HTN)
Beyond the preview
Go deeper on 2008-005500-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005500-10.